318 related articles for article (PubMed ID: 16516981)
21. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
[TBL] [Abstract][Full Text] [Related]
22. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
[TBL] [Abstract][Full Text] [Related]
23. [Comparative study on the role of parent Campylobacter jejuni and galE mutant in inducing experimental peripheral nerve damage].
Shu XM; Cai FC; Zhang XP
Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):256-60. PubMed ID: 15924714
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
25. [Experimental study on an animal model of axonal form Guillain-Barre syndrome].
Wang Q; Wang H; Zhang H
Zhonghua Yi Xue Za Zhi; 2000 Dec; 80(12):947-9. PubMed ID: 11236637
[TBL] [Abstract][Full Text] [Related]
26. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome.
Yuki N; Handa S; Tai T; Takahashi M; Saito K; Tsujino Y; Taki T
J Neurol Sci; 1995 May; 130(1):112-6. PubMed ID: 7544402
[TBL] [Abstract][Full Text] [Related]
27. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.
Yuki N; Yoshino H; Sato S; Shinozawa K; Miyatake T
Muscle Nerve; 1992 Aug; 15(8):899-903. PubMed ID: 1495505
[TBL] [Abstract][Full Text] [Related]
28. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
29. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
30. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
Prendergast MM; Lastovica AJ; Moran AP
Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
[TBL] [Abstract][Full Text] [Related]
31. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
[TBL] [Abstract][Full Text] [Related]
32. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
33. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
[TBL] [Abstract][Full Text] [Related]
34. [Pathogenesis of Guillain-Barré syndrome and Fisher's syndrome: molecular mimicry between antecedent infectious agents and components of nerve tissues].
Yuki N
Rinsho Shinkeigaku; 1995 Dec; 35(12):1373-5. PubMed ID: 8752400
[TBL] [Abstract][Full Text] [Related]
35. Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits.
Ang CW; Noordzij PG; de Klerk MA; Endtz HP; van Doorn PA; Laman JD
Infect Immun; 2002 Sep; 70(9):5081-5. PubMed ID: 12183556
[TBL] [Abstract][Full Text] [Related]
36. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
Koga M; Gilbert M; Li J; Yuki N
PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
[TBL] [Abstract][Full Text] [Related]
37. The immunobiology of Guillain-Barré syndromes.
Willison HJ
J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
[TBL] [Abstract][Full Text] [Related]
38. Origin of ganglioside complex antibodies in Guillain-Barré syndrome.
Kuijf ML; Godschalk PC; Gilbert M; Endtz HP; Tio-Gillen AP; Ang CW; van Doorn PA; Jacobs BC
J Neuroimmunol; 2007 Aug; 188(1-2):69-73. PubMed ID: 17604126
[TBL] [Abstract][Full Text] [Related]
39. Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies.
Perera VN; Nachamkin I; Ung H; Patterson JH; McConville MJ; Coloe PJ; Fry BN
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):27-36. PubMed ID: 17374131
[TBL] [Abstract][Full Text] [Related]
40. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
Gregson NA; Rees JH; Hughes RA
J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]